AbbVie rockets on upbeat forecast, despite 4th-qtr profit plunge

26 January 2018
abbvie-logo-big

US drugmaker AbbVie (NYSE: ABBV) was another victim of tax charges that hit its fourth-quarter 2017 results today, but still the firm’s shares jumped a significant 8.98% to $118.02 by mid-morning on strong sales of its lead product and an upbeat outlook for the current year.

Net revenue in the fourth-quarter rose nearly 14% to $7.74 billion, resulting in $1.48 earnings per share, and beating analysts’ average expectations of $1.44 EPS on revenue of $7.53 billion, according to Thomson Reuters.

As a result of a $1.14 billion income tax charges in the quarter, with net income attributable to AbbVie falling to $52 million compared with $1.29 billion in the like year-earlier quarter.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical